KAHR Medical LTD.
|KAHR Medical LTD. Patent applications|
|Patent application number||Title||Published|
|20150376260||Stable Form Of Signal Converting Protein Fusion Proteins, And Methods Of Use And Preparation Thereof - A stable fusion protein, wherein in solution, a majority of the fusion proteins are in the homo-hexamer form, which may be prepared for example as a CTLA4-FasL fusion protein.||12-31-2015|
|20140147462||COMPOSITIONS AND METHODS FOR TREATMENT OF HEMATOLOGICAL MALIGNANCIES - Use of a chimeric protein selected from the group consisting of CTLA4-FasL and CD40-FasL proteins for treatment of lymphoma and/or a multiple myeloma and/or a leukemia as described herein, and pharmaceutical compositions and methods of treatment thereof.||05-29-2014|